Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT

NCT05938478 · clinicaltrials.gov ↗

RECRUITING

Status

900

Enrollment

OTHER

Sponsor class

Conditions

Atopic Dermatitis
Eczema

Interventions

DRUG: Tralokinumab

Sponsor

University of California, San Diego

Collaborators

[object Object]
[object Object]